SEC Form 4 · accession 0001387131-17-004553
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tommy G Thompson
Director
Period of report
Aug 30, 2017
Accepted (ET)
Sep 1, 2017 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 30, 2017 | P | 5,000 | $5.99 | A | 674,500 | I | See Footnote |
| Common StockF3 | holding | — | — | — | 1,001 | I | See Footnote | |
| Common Stock | holding | — | — | — | 3,555 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades ranging from $5.96 to $6.0; the price reported reflects the weighted average price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request of the SEC staff, the issuer or the security holder of the issuer.
- F2Owned by Thompson Family Investments, LLC an entity solely owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.
- F3Owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.